Comparison of Chitodex Gel Vs NexFoam on Post-operative Outcomes in the Treatment of Chronic Rhinosinusitis

NCT05083741 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and outcomes of Chitodex gel plus Kenalog versus Nexfoam plus Kenalog in patients with chronic rhinosinusitis (CRS) undergoing sinus surgery. Both dressings are already known to be beneficial in controlling postoperative bleeding and promote wound healing.

Conditions

  • Chronic Rhinosinusitis

Interventions

DEVICE

Chitogel

post-operative dressing within standard of care

DEVICE

Nexfoam

post-operative dressing within standard of care

Sponsors & Collaborators

  • St. Louis University

    lead OTHER

Principal Investigators

  • Joseph D Brunworth, MD · Department of Otolaryngology-Head & Neck Surgery

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-27
Primary Completion
2024-08-08
Completion
2024-08-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05083741 on ClinicalTrials.gov